Trademark: 79305516
Word
HEMESIGHT
Status
Registered
Status Code
700
Status Date
Tuesday, May 24, 2022
Serial Number
79305516
Registration Number
6733728
Registration Date
Tuesday, May 24, 2022
Mark Type
4000
Filing Date
Tuesday, December 15, 2020
Published for Opposition
Tuesday, March 8, 2022

Trademark Owner History
Otsuka Pharmaceutical Co., Ltd. - Original Registrant

Classifications
5 Diagnostic preparations for medical purposes for diagnosing and treating cancer through genetic testing; diagnostic reagents for medical use in diagnosing cancer
44 Providing medical information in the field of genetic and sequencing testing for the diagnosis and treatment of cancer; medical diagnostic services in the nature of performing diagnosis of disease in the field of cancer diagnostics; medical testing for diagnostic or treatment purposes, namely, genetic testing and sequencing tests for diagnosis and treatment of cancer
HEME SIGHT

Trademark Events
Mar 13, 2023
New Representative At Ib Received
Oct 2, 2022
Final Decision Transaction Processed By Ib
Sep 8, 2022
Final Disposition Notice Sent To Ib
Sep 8, 2022
Final Disposition Processed
Aug 24, 2022
Final Disposition Notice Created, To Be Sent To Ib
May 24, 2022
Notice Of Registration Confirmation Emailed
May 24, 2022
Registered-Principal Register
Mar 8, 2022
Official Gazette Publication Confirmation E-Mailed
Mar 8, 2022
Published For Opposition
Mar 7, 2022
Notification Processed By Ib
Feb 16, 2022
Notification Of Possible Opposition Sent To Ib
Feb 16, 2022
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 16, 2022
Notification Of Notice Of Publication E-Mailed
Jan 28, 2022
Approved For Pub - Principal Register
Jan 28, 2022
Examiner's Amendment Entered
Jan 28, 2022
Notification Of Examiners Amendment E-Mailed
Jan 28, 2022
Examiners Amendment E-Mailed
Jan 28, 2022
Examiners Amendment -Written
Dec 17, 2021
Teas/Email Correspondence Entered
Dec 16, 2021
Correspondence Received In Law Office
Dec 16, 2021
Teas Response To Office Action Received
Jul 5, 2021
Refusal Processed By Ib
Jun 16, 2021
Non-Final Action Mailed - Refusal Sent To Ib
Jun 16, 2021
Refusal Processed By Mpu
Jun 11, 2021
Non-Final Action (Ib Refusal) Prepared For Review
Jun 10, 2021
Non-Final Action Written
Jun 2, 2021
Assigned To Examiner
Mar 16, 2021
Application Filing Receipt Mailed
Mar 12, 2021
New Application Office Supplied Data Entered
Mar 11, 2021
Limitation From Original Application Entered
Mar 4, 2021
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24